Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 Randomized Open-Label Study of Sarpogrelate versus Cilostazol in Type 2 Diabetes Patients with Carotid Artery Thickening
KCT0006237Phase 4Completed
- Sponsor
- Yuhan
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sarpogrelate, cilostazol in type 2 diabetes mellitus (T2DM), carotid atheroma (CAS), sponsored by Yuhan. Started Sep 2021; status: completed.
02
Drugs
sarpogrelatecilostazol
03
Conditions
type 2 diabetes mellitus (T2DM)carotid atheroma (CAS)
Beyond the preview
Go deeper on KCT0006237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006237.